RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Return on Assets

REGENERON PHARMACEUTICALS, INC.【REGN】

Market cap
$86B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 202412.5-1.81%
Dec 31, 202312.7-20.09%
Dec 31, 202215.9-58.11%
Dec 31, 202137.9+72.47%
Dec 31, 202022+37.89%
Dec 31, 201915.9-33.17%
Dec 31, 201823.9+56.60%
Dec 31, 201715.2+7.03%
Dec 31, 201614.2+6.04%
Dec 31, 201513.4+31.57%
Dec 31, 201410.2-39.54%
Dec 31, 201316.9-61.73%
Dec 31, 201244.1-339.83%
Dec 31, 2011-18.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)